Assessing the risk of bias and publication bias should be integral parts of the systematic review

Leggi l'articolo originale

We have read with interest the article by McNamara MG et al. [1] entitled ‘Sorafenib as first-line therapy in patients with advanced Child-Pugh B hepatocellular carcinoma meta-analysis’ published recently in the Journal.

Lascia un commento